previous compound ID: 2253 next compound
InChIKey: UQZKYYIKWZOKKD-UHFFFAOYSA-N
SMILES: CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "GW Carlile" "JW Hanrahan" "J Goepp" "R Robert" "SD Macknight" "DY Thomas" "J Liao" "E Matthes" "D Rotin"

chemical graph of compound 2253





CID is 9568
synonyms found at PubChem are:
Orphenadrine hydrochloride, 341-69-5, Orphenadrine HCl, Mebedrol, Mephenamin, Mefenamin hydrochloride, Mephenamin forte, Mephenamin hydrochloride, Orfenadrin hydrochloride, Mephenamine hydrochloride, Orphenadrine (hydrochloride), BF 5930, BG 5930, BS 5930, EINECS 206-435-4, NSC 82357, MLS000069427, 2-Dimethylaminoethyl 2-methylbenzhydryl ether hydrochloride, Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-, hydrochloride, SMR000058999, Disipal (TN), Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, hydrochloride, Orphenadrine (Chloride), N,N-Dimethyl-2-(o-methyl-alpha-phenylbenzyloxy)ethylamine hydrochloride, beta-Dimethylaminoethyl 2-methylbenzhydryl ether hydrochloride, N,N-Dimethyl-2-(2-methylbenzhydryloxy)ethylamine hydrochloride, ETHYLAMINE, N,N-DIMETHYL-2-((o-METHYL-alpha-PHENYLBENZYL)OXY)-, HYDROCHLORIDE, CHEBI:60902, SR-01000002975, orphenadrine*HCl, N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;hydrochloride, Prestwick_663, Disipal hydrochloride, Orphenadrine Chloride, Opera_ID_658, AC1L1TBY, AC1Q3BLK, AC1Q3DQC, Orphenedrine hydrochloride, DSSTox_CID_5815, CAS-341-69-5, DSSTox_RID_77934, DSSTox_GSID_25815, REGID_for_CID_9568, MLS001148572, MLS002548882, MLS006011645, Disipal, Orphenadrinhydrochlorid, SCHEMBL1235378, CHEMBL1201023, DTXSID5025815, (+/-)-orphenadrine hydrochloride, MolPort-002-111-239, HMS1568P19, 247046-64-6 (citrate), HY-B1126, NSC82357, o-Methyldiphenhydramine hydrochloride, Tox21_301927, Tox21_500884, MFCD00012480, NSC-82357, AKOS024307520, WLN: 1N1&2OYR&R B1 &GH, API0003697, CCG-220239, CCG-222188, CS-4723, LP00884, LS-1218, MCULE-1907411306, NC00465, NCGC00089814-04, NCGC00094204-01, NCGC00094204-02, NCGC00255176-01, NCGC00261569-01, AN-23409, CPD000058999, SAM002264628, EU-0100884, FT-0631984, O0406, Orphenadrine hydrochloride, >=98.0% (AT), ST50320118, WLN: 1N1 & 2OYR & R B1 & GH, D02599, O 3752, Dimethyl-[2-(2-methyl-benzhydryloxy)-aethyl]-amin, dimethyl-[2-(2-methyl-benzhydryloxy)-ethyl]-amine, J-019475, SR-01000002975-2, SR-01000002975-7, dimethyl{2-[(2-methylphenyl)phenylmethoxy]ethyl}amine, chloride, N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine hydrochloride, N,N-dimethyl-2-[o-tolyl(phenyl)methoxy]ethanamine hydrochloride, Ethylamine,N-dimethyl-2-[phenyl-(o-tolyl)methoxy]-, hydrochloride, N,N-Dimethyl-2-[(.alpha.-o-tolylbenzyl)oxy]ethylamine hydrochloride, N,N-Dimethyl-2-[.alpha.-(o-tolyl)benzyloxy]ethylamine hydrochloride, dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine hydrochloride, Ethanamine,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-, hydrochloride, Ethylamine,N-dimethyl-2-[.alpha.-(o-tolyl)benzyloxy]-, hydrochloride, N,N-Dimethyl-2-(o-methyl-.alpha.-phenylbenzyloxy)ethylamine hydrochloride, N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine hydrochloride, Orphenadrine hydrochloride, European Pharmacopoeia (EP) Reference Standard, Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, hydrochloride (9CI), Ethylamine,N-dimethyl-2-[(o-methyl-.alpha.-phenylbenzyl)oxy]-, hydrochloride, Orphenadrine for peak identification, European Pharmacopoeia (EP) Reference Standard, AC1LCW8R, AKOS015909563, I14-31866, N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine; hydron; chloride, N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanaminium chloride, N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine hydrochloride